Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  p53-HDM2 protein-protein interaction inhibitor MI-773
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: TCD13388, NCI-2014-02578, 2013-002325-33, U1111-1144-8349, NCT01985191
Start Over